ADDF and Harrington Discovery Institute Announce 2015 Award Recipients

08/26/2015

Collaboration advances development of therapeutics for the treatment of Alzheimer’s Disease.

ADDF to be Featured in Upcoming Episode of Innovations with Ed Begley Jr.

08/24/2015

The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year. 

Goodes Family & The ADDF Create New Prize for Alzheimer’s Drug Development Researchers

08/12/2015

Melvin R. Goodes Prize supports innovative projects by top researchers while honoring pioneering legacy of former Warner-Lambert CEO.

Carmel Valley, California Winery Launches Two New Wines to Benefit the ADDF

08/06/2015

Carmel Valley's newest winery, Jarman Wines, will introduce two premium varietals to benefit the Alzheimer's Drug Discovery Foundation (ADDF) and to honor the matriarch of the family whose name graces the wines created for her.

Grantees at Lou Rovo Center for Brain Health Recruiting for New Alzheimer’s Disease Trial

07/30/2015

Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new, multicenter Alzheimer’s disease (AD) treatment trial, Rasagiline Rescue (R2), which is designed to determine if treatment with rasagiline is associated with improved brain glucose metabolism and improvement in memory.

Adam Rowe Reflects: A Mother’s Voice

05/08/2015

A mother's voice is the first thing we hear from the time we exit the womb. And its the voice we continue to hear throughout our lives. We model our mother's voice when we first learn to talk. The same voice guides us as we begin to walk. It warns you of potential harm and radiates warmth when you need consolation.

Alzheimer’s Drug Discovery Foundation Connoisseur’s Dinner Raises $2.8 Million

05/04/2015

On Monday, April 27, 2015, American theatre director, choreographer, film director, and performer Susan Stroman hosted the ADDF's Ninth Annual Connoisseur’s Dinner. More than $2.8 million was raised to support Alzheimer's drug discovery and development.

Diane Rehm Hosts 2015 Great Ladies Luncheon & Fashion Show

04/17/2015

On Wednesday, April 15, 2015, renowned journalist and NPR host Diane Rehm welcomed guests to the ADDF's Fifth Annual Great Ladies Luncheon & Fashion Show in Washington, DC. Rehm, who has long used her public platform to raise awareness for Alzheimer’s disease, spoke eloquently about the need to increase support for drug discovery for Alzheimer's.

Asceneuron Awarded Alzheimer’s Drug Discovery Foundation Grant

04/09/2015

Asceneuron SA, an emerging leader in the development of novel, oral small molecule therapeutics targeting tauopathies for Alzheimer’s and related neurodegenerative diseases, today announced that the ADDF awarded it a $325,000 grant to support the development of Asceneuron’s tau modulators.

GliaCure Receives $1 Million Grant for Alzheimer’s Clinical Trial

03/17/2015

The ADDF announced today that it has awarded $1 million to GliaCure, a biotechnology company developing innovative therapies based on glial targets, to co-fund a Phase 1b clinical trial in patients with mild to moderate Alzheimer’s disease. The study, which recently began screening volunteers, will determine the safety and tolerability of GliaCure’s primary clinical candidate, GC021109.